News Sentiment

PULM sentiment intelligence

Pulmatrix Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.72 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

72/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +22.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Pulmatrix (NASDAQ: PULM) to Merge with Eos; 75.2M Shares to Be Issued

Market Reaction

Balanced read

46/100 confidence

News tone and price action are not far from neutral.

Primary event Deals and strategy 72/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 22.9% over four weeks
Fair value -51.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 37
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 8
Stock Titan 7
TradingKey 7
PR Newswire 6
Market source 5
Moomoo 2
Finviz 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Earnings 16
Deals and strategy 16
Market update 15
Analyst action 1
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50
TradingView Direct company coverage

Number of shareholders of Pulmatrix, Inc. – NASDAQ:PULM

This article provides general financial information for Pulmatrix, Inc. (NASDAQ: PULM) as found on TradingView. It indicates that the current market status is closed and offers navigation to various financial and community features related to the company. The core content focuses

Tone
Neutral 50/100
Event
Market update
Published
10 May 2026 10:39
Source
TradingView
Simply Wall Street Direct company coverage

Pulmatrix (Nasdaq:PULM) - Stock Analysis

This Simply Wall St analysis provides an overview of Pulmatrix (PULM), a biopharmaceutical company with a market cap of US$5.0m. The report summarizes its valuation, growth prospects, past performance, financial health, and recent news including a recent acquisition agreement by

Tone
Negative 29/100
Event
Deals and strategy
Published
08 May 2026 06:38
Source
Simply Wall Street
Quantisnow Direct company coverage

Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

Pulmatrix announced its second quarter 2025 financial results and a plan to divest its inhalation assets. This news was delivered by Quantisnow, a real-time market data and news platform for retail investors. The company, trading under the symbol PULM, is in the healthcare sector

Tone
Neutral 50/100
Event
Earnings
Published
29 Apr 2026 16:40
Source
Quantisnow
Investing.com South Africa Direct company coverage

Pulmatrix closes $1M preferred stock placement with Eos affiliate By Investing.com

Pulmatrix, Inc. (NASDAQ:PULM) has secured approximately $1 million through a private placement of Series B Convertible Preferred Stock with an affiliate of Eos SENOLYTIX, Inc. This strategic move is part of Pulmatrix's planned merger with Eos, with the preferred stock convertible

Tone
Neutral 50/100
Event
Deals and strategy
Published
26 Apr 2026 03:38
Source
Investing.com South Africa